Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy

Diffuse optical spectroscopy (DOS) and diffuse optical imaging (DOI) are non-invasive diagnostic techniques that employ near-infrared (NIR) light to quantitatively characterize the optical properties of centimeter-thick, multiple-scattering tissues. Although NIR was first applied to breast diaphanography more than 70 years ago, quantitative optical methods employing time- or frequency-domain 'photon migration' technologies have only recently been used for breast imaging. Because their performance is not limited by mammographic density, optical methods can provide new insight regarding tissue functional changes associated with the appearance, progression, and treatment of breast cancer, particularly for younger women and high-risk subjects who may not benefit from conventional imaging methods. This paper reviews the principles of diffuse optics and describes the development of broadband DOS for quantitatively measuring the optical and physiological properties of thick tissues. Clinical results are shown highlighting the sensitivity of diffuse optics to malignant breast tumors in 12 pre-menopausal subjects ranging in age from 30 to 39 years and a patient undergoing neoadjuvant chemotherapy for locally advanced breast cancer. Significant contrast was observed between normal and tumor regions of tissue for deoxy-hemoglobin (p = 0.005), oxy-hemoglobin (p = 0.002), water (p = 0.014), and lipids (p = 0.0003). Tissue hemoglobin saturation was not found to be a reliable parameter for distinguishing between tumor and normal tissues. Optical data were converted into a tissue optical index that decreased 50% within 1 week in response to neoadjuvant chemotherapy. These results suggest a potential role for diffuse optics as a bedside monitoring tool that could aid the development of new strategies for individualized patient care

RFQ Reaction Cells for AMS: Developments and Applications

The use of anion-gas interactions in Radiofrequency Quadrupole (RFQ) ion guide reaction cells has been shown to be very effective in the elimination of a number of atomic and molecular isobars which have caused difficulties for Accelerator Mass Spectrometry (AMS) measurements [1,2]. This presentation begins with a review of the early work leading to the use of ion-gas reactions and continues with a discussion the recent measurements of the efficacy of this technique, some of which involve fluoride molecular anions. However, the transformation of the equipment used for these proof-of-principle measurements into a system suitable for routine analysis has required attention to aspects of the ion beam transport and gas handling subsystems. For example, the cross sections of the ion-gas reactions, involving both the analyte ion as well as the isobar, are critically dependent on the ion energy which has to be reduced from the ion source energy, usually between 20 and 80 keV, to energies typically in the range of several eV, a task complicated by the energy spread and divergence of beams from AMS sputter sources. With simulations using SIMION 8.1 [3] and tests of promising configurations in a laboratory system, principles for the design of the retarder optics have been developed. These are discussed, along with their planned implementation in a next generation analytical system